Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma

Figure 2

Significantly differentially expressed lysine crotonylation regulators in HNSCC with different clinicopathological features. (a) KAT2B expression in HNSCC patients with early T stage (T1 and T2) and advanced T stage (T3 and T4). (b) HDAC2 expression in HNSCC patients with and without lymph node metastasis. (c–k) Expression levels of DPF2, HDAC2, HDAC3, HDAC8, KAT8, MLLT3, SIRT1, TAF1, and YEATS2 in HNSCC patients with different histologic grades, respectively.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)